Trematocine-derived antimicrobial peptides from the Antarctic fish Trematomus bernacchaii: potent antibacterial agents against ESKAPE pathogens

This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 15; p. 1447301
Main Authors Squitieri, Damiano, Massaro, Federica, Graziano, Monica Mollica, Borocci, Stefano, Cacaci, Margherita, Di Vito, Maura, Porcelli, Fernando, Rosato, Roberto, Ceccacci, Francesca, Sanguinetti, Maurizio, Buonocore, Francesco, Bugli, Francesca
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 07.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish , aiming to increase their positive charge. The selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE ( , and family) pathogens for both Trem-HK and Trem-HSK. Firstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations. Assessment of toxicity using the model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for , suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs.
AbstractList This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish Trematomus bernacchii, aiming to increase their positive charge.IntroductionThis study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish Trematomus bernacchii, aiming to increase their positive charge.The selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae family) pathogens for both Trem-HK and Trem-HSK.MethodsThe selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae family) pathogens for both Trem-HK and Trem-HSK.Firstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations.ResultsFirstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations.Assessment of in vivo toxicity using the Galleria mellonella model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for Acinetobacter baumannii, suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs.DiscussionAssessment of in vivo toxicity using the Galleria mellonella model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for Acinetobacter baumannii, suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs.
This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish , aiming to increase their positive charge. The selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE ( , and family) pathogens for both Trem-HK and Trem-HSK. Firstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations. Assessment of toxicity using the model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for , suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs.
IntroductionThis study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish Trematomus bernacchii, aiming to increase their positive charge.MethodsThe selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae family) pathogens for both Trem-HK and Trem-HSK.ResultsFirstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations.DiscussionAssessment of in vivo toxicity using the Galleria mellonella model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for Acinetobacter baumannii, suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs.
Author Squitieri, Damiano
Cacaci, Margherita
Buonocore, Francesco
Ceccacci, Francesca
Porcelli, Fernando
Borocci, Stefano
Graziano, Monica Mollica
Massaro, Federica
Sanguinetti, Maurizio
Rosato, Roberto
Bugli, Francesca
Di Vito, Maura
AuthorAffiliation 1 Department of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Catholic University of the Sacred Heart , Rome , Italy
2 Department for Innovation in Biological, Agro-Food and Forest Systems (DIBAF), University of Tuscia , Viterbo , Italy
4 Department of Laboratory Sciences and Infectious Diseases, A. Gemelli University Hospital Foundation IRCCS , Rome , Italy
3 Institute for Biological Systems of Italian National Research Council (ISB-CNR), Secondary Office of Rome-Reaction Mechanisms c/o Department of Chemistry, La Sapienza University of Rome , Rome , Italy
AuthorAffiliation_xml – name: 1 Department of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Catholic University of the Sacred Heart , Rome , Italy
– name: 4 Department of Laboratory Sciences and Infectious Diseases, A. Gemelli University Hospital Foundation IRCCS , Rome , Italy
– name: 3 Institute for Biological Systems of Italian National Research Council (ISB-CNR), Secondary Office of Rome-Reaction Mechanisms c/o Department of Chemistry, La Sapienza University of Rome , Rome , Italy
– name: 2 Department for Innovation in Biological, Agro-Food and Forest Systems (DIBAF), University of Tuscia , Viterbo , Italy
Author_xml – sequence: 1
  givenname: Damiano
  surname: Squitieri
  fullname: Squitieri, Damiano
– sequence: 2
  givenname: Federica
  surname: Massaro
  fullname: Massaro, Federica
– sequence: 3
  givenname: Monica Mollica
  surname: Graziano
  fullname: Graziano, Monica Mollica
– sequence: 4
  givenname: Stefano
  surname: Borocci
  fullname: Borocci, Stefano
– sequence: 5
  givenname: Margherita
  surname: Cacaci
  fullname: Cacaci, Margherita
– sequence: 6
  givenname: Maura
  surname: Di Vito
  fullname: Di Vito, Maura
– sequence: 7
  givenname: Fernando
  surname: Porcelli
  fullname: Porcelli, Fernando
– sequence: 8
  givenname: Roberto
  surname: Rosato
  fullname: Rosato, Roberto
– sequence: 9
  givenname: Francesca
  surname: Ceccacci
  fullname: Ceccacci, Francesca
– sequence: 10
  givenname: Maurizio
  surname: Sanguinetti
  fullname: Sanguinetti, Maurizio
– sequence: 11
  givenname: Francesco
  surname: Buonocore
  fullname: Buonocore, Francesco
– sequence: 12
  givenname: Francesca
  surname: Bugli
  fullname: Bugli, Francesca
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39171261$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAQxyNUREvpC3BAPnLZxY6dxOGCVtUCFZVAokjcrIk93rhK4mB7K_UpeGW8H1QtB3zwWOP__MbjmZfFyeQnLIrXjC45l-07OzrdLUtaiiUTouGUPSvOWF2LBaflz5NH59PiIsZbmpegZd5fFKe8ZQ0ra3ZW_L4JOELy2k24MBjcHRoCU3IZH3znYCAzzskZjMQGP5LUI1lNCYJOThPrYk-OiHEbSYdhAq17cO49mX3CKe1pHeiU4ZkGm-yL2YCbYiLr719W39ZkhtT7fBNfFc8tDBEvjva8-PFxfXP5eXH99dPV5ep6oUXdpgVKgK7T0lhTN4JykLKSLec2e01j68rkT6pLLWtdNqLSbVfWutGCImN1hS0_L64OXOPhVs3BjRDulQen9g4fNgpCrnBARbFCQMltW2kBVndGCkPB0lbyTgPNrA8H1rztRjQ6FxhgeAJ9ejO5Xm38nWKM86qWVSa8PRKC_7XFmNToosZhgAn9NipO26xjtJJZ-uZxsocsf1uaBeVBkPsXY0D7IGFU7UZH7UdH7UZHHUcnB8l_grRLkJzfPdgN_wv9A4uezrI
CitedBy_id crossref_primary_10_1016_j_micpath_2025_107361
Cites_doi 10.1128/spectrum.04385-22
10.3109/02713688609015126
10.3389/fmicb.2022.1039687
10.1128/CMR.00181-19
10.1002/pep2.24122
10.1007/978-0-387-46312-4
10.1007/978-1-4419-6327-7_2
10.3390/ijms21197047
10.1007/s12551-021-00784-y
10.1016/j.micres.2022.127152
10.1007/s00249-010-0661-4
10.1080/22221751.2022.2030196
10.1021/acsami.2c05979
10.1128/AAC.02097-16
10.1016/S2468-2667(22)00225-0
10.2147/IDR.S428103
10.1016/j.dci.2019.02.012
10.4103/joacp.JOACP_349_15
10.1016/j.ejps.2022.106363
10.1099/acmi.ac2021.po0053
10.1016/j.micpath.2021.105040
10.1016/S1473-3099(20)30327-3
10.1021/acsabm.3c00824
10.3389/fimmu.2023.1168517
10.4161/viru.24930
10.3390/molecules27092675
10.3389/fcimb.2020.540898
10.3389/fcimb.2022.823684
10.1016/S0014-5793(01)02648-5
10.3390/antibiotics9020066
10.1128/mSphere.00775-20
10.1016/j.bbamem.2023.184260
10.1093/jac/dkq037
10.1016/S0140-6736(21)02724-0
10.1002/prot.23188
10.1016/j.ejmech.2023.116072
ContentType Journal Article
Copyright Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli.
Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli. 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli
Copyright_xml – notice: Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli.
– notice: Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli. 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fmicb.2024.1447301
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Open Access Journals (DOAJ)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-302X
ExternalDocumentID oai_doaj_org_article_0e5eae83f95c4afcbd84d0af0983bca0
PMC11335685
39171261
10_3389_fmicb_2024_1447301
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
ECGQY
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c469t-e8aabbc8dfd67403a8858933fabbd7f65d33862c86c2745c9b26c7c40e1165e93
IEDL.DBID M48
ISSN 1664-302X
IngestDate Wed Aug 27 01:32:00 EDT 2025
Thu Aug 21 18:34:48 EDT 2025
Fri Jul 11 04:19:38 EDT 2025
Mon Jul 21 05:55:57 EDT 2025
Thu Apr 24 22:59:53 EDT 2025
Tue Jul 01 02:19:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords membranolytic agents
ESKAPE pathogens
antimicrobial resistance
antimicrobial peptides
multi-drug resistant bacteria
Language English
License Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-e8aabbc8dfd67403a8858933fabbd7f65d33862c86c2745c9b26c7c40e1165e93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors share last authorship
These authors have contributed equally to this work and share first authorship
Edited by: Yovani Marrero-Ponce, University of Valencia, Spain
Reviewed by: Dexi Li, Henan Agricultural University, China
Ruoyu Mao, Chinese Academy of Agricultural Sciences, China
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fmicb.2024.1447301
PMID 39171261
PQID 3095681058
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_0e5eae83f95c4afcbd84d0af0983bca0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11335685
proquest_miscellaneous_3095681058
pubmed_primary_39171261
crossref_primary_10_3389_fmicb_2024_1447301
crossref_citationtrail_10_3389_fmicb_2024_1447301
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-08-07
PublicationDateYYYYMMDD 2024-08-07
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-07
  day: 07
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in microbiology
PublicationTitleAlternate Front Microbiol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References ref13
Schäfer (ref35) 2020; 10
ref14
Loh (ref24) 2013; 4
Shields (ref37) 2017; 61
Browne (ref4) 2020; 21
Hussain (ref17) 2021; 158
Jean (ref18) 2022; 12
O’Neill (ref32) 2016
Luo (ref26) 2023; 181
Kapoor (ref20) 2017; 33
Buonocore (ref6) 2019; 96
Della Pelle (ref11) 2020; 9
Abebe (ref1) 2023; 16
Ayobami (ref3) 2022; 11
Koo (ref21) 2019; 111
Niu (ref31) 2020; 5
Di Vito (ref12) 2023; 11
Garcia Maset (ref16) 2022; 14
Lakowicz (ref22) 2006
Chen (ref8) 2023; 14
Straus (ref38) 2024; 1866
Cardoso (ref7) 2021; 13
Wimley (ref40) 2010; 677
Schwarz (ref36) 2010; 65
Murray (ref30) 2022; 399
Dathe (ref9) 2001; 501
Louis-Jeune (ref25) 2012; 80
Phillips (ref34) 1986; 5
Li (ref23) 2022; 27
Pandey (ref33) 2023; 13
(ref39) 2024
Freire (ref15) 2011; 40
Mba (ref28) 2022; 4
De Oliveira (ref10) 2020; 33
Bugli (ref5) 2022; 263
Alfred (ref2) 2024; 7
Magana (ref27) 2020; 20
Mestrovic (ref29) 2022; 7
Ji (ref19) 2024; 265
References_xml – volume: 11
  start-page: e0438522
  year: 2023
  ident: ref12
  article-title: A new potential resource in the fight against Candida auris: the Cinnamomum zeylanicum essential oil in synergy with antifungal drug
  publication-title: Microbiol. Spectr.
  doi: 10.1128/spectrum.04385-22
– volume: 5
  start-page: 611
  year: 1986
  ident: ref34
  article-title: Acrylamide and iodide fluorescence quenching as a structural probe of tryptophan microenvironment in bovine lens crystallins
  publication-title: Curr. Eye Res.
  doi: 10.3109/02713688609015126
– volume: 13
  start-page: 13
  year: 2023
  ident: ref33
  article-title: β-LacFamPred: An online tool for prediction and classification of β-lactamase class, subclass, and family
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2022.1039687
– volume: 33
  start-page: e00181-19
  year: 2020
  ident: ref10
  article-title: Antimicrobial resistance in ESKAPE pathogens
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.00181-19
– volume: 111
  start-page: e24122
  year: 2019
  ident: ref21
  article-title: Antimicrobial peptides under clinical investigation
  publication-title: Peptide Sci.
  doi: 10.1002/pep2.24122
– start-page: 1
  volume-title: Principles of fluorescence spectroscopy
  year: 2006
  ident: ref22
  doi: 10.1007/978-0-387-46312-4
– volume: 677
  start-page: 14
  year: 2010
  ident: ref40
  article-title: Energetics of peptide and protein binding to lipid membranes
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-1-4419-6327-7_2
– volume: 21
  start-page: 1
  year: 2020
  ident: ref4
  article-title: A new era of antibiotics: the clinical potential of antimicrobial peptides
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21197047
– volume: 13
  start-page: 35
  year: 2021
  ident: ref7
  article-title: Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunities
  publication-title: Biophys. Rev.
  doi: 10.1007/s12551-021-00784-y
– volume: 263
  start-page: 127152
  year: 2022
  ident: ref5
  article-title: Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: a review
  publication-title: Microbiol. Res.
  doi: 10.1016/j.micres.2022.127152
– volume: 40
  start-page: 481
  year: 2011
  ident: ref15
  article-title: Using zeta-potential measurements to quantify peptide partition to lipid membranes
  publication-title: Eur. Biophys. J.
  doi: 10.1007/s00249-010-0661-4
– volume: 11
  start-page: 443
  year: 2022
  ident: ref3
  article-title: Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis
  publication-title: Emerg. Microbes Infect.
  doi: 10.1080/22221751.2022.2030196
– volume: 14
  start-page: 32855
  year: 2022
  ident: ref16
  article-title: Evaluation of the antimicrobial activity in host-mimicking media and in vivo toxicity of antimicrobial polymers as functional mimics of AMPs
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.2c05979
– volume: 61
  start-page: e02097-16
  year: 2017
  ident: ref37
  article-title: Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of Carbapenem-resistant Klebsiella pneumoniae infections
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.02097-16
– volume: 7
  start-page: e897
  year: 2022
  ident: ref29
  article-title: The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(22)00225-0
– volume: 16
  start-page: 7641
  year: 2023
  ident: ref1
  article-title: Methicillin resistant Staphylococcus aureus: molecular mechanisms underlying drug resistance development and novel strategies to combat
  publication-title: Infect. Drug Resist.
  doi: 10.2147/IDR.S428103
– volume: 96
  start-page: 9
  year: 2019
  ident: ref6
  article-title: Fish-derived antimicrobial peptides: activity of a chionodracine mutant against bacterial models and human bacterial pathogens
  publication-title: Dev. Comp. Immunol.
  doi: 10.1016/j.dci.2019.02.012
– volume: 33
  start-page: 300
  year: 2017
  ident: ref20
  article-title: Action and resistance mechanisms of antibiotics: a guide for clinicians
  publication-title: J. Anaesthesiol. Clin. Pharmacol.
  doi: 10.4103/joacp.JOACP_349_15
– volume: 181
  start-page: 106363
  year: 2023
  ident: ref26
  article-title: Advancements, challenges and future perspectives on peptide-based drugs: focus on antimicrobial peptides
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2022.106363
– volume: 4
  year: 2022
  ident: ref28
  article-title: Antimicrobial resistance: revisiting the mechanisms of resistance
  publication-title: Access Microbiol.
  doi: 10.1099/acmi.ac2021.po0053
– volume: 158
  start-page: 105040
  year: 2021
  ident: ref17
  article-title: Genetic basis of molecular mechanisms in β-lactam resistant gram-negative bacteria
  publication-title: Microb. Pathog.
  doi: 10.1016/j.micpath.2021.105040
– ident: ref13
– volume: 20
  start-page: e216
  year: 2020
  ident: ref27
  article-title: The value of antimicrobial peptides in the age of resistance
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(20)30327-3
– volume: 7
  start-page: 220
  year: 2024
  ident: ref2
  article-title: Unraveling the effects of cationic peptides on vesicle structures: insights into peptide-membrane interactions
  publication-title: ACS Appl. Bio Mater.
  doi: 10.1021/acsabm.3c00824
– volume: 14
  start-page: 14
  year: 2023
  ident: ref8
  article-title: A novel antimicrobial peptide screened by a Bacillus subtilis expression system, derived from Larimichthys crocea ferritin H, exerting bactericidal and parasiticidal activities
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2023.1168517
– volume: 4
  start-page: 419
  year: 2013
  ident: ref24
  article-title: Galleria mellonella larvae as an infection model for group a streptococcus
  publication-title: Virulence
  doi: 10.4161/viru.24930
– volume: 27
  start-page: 2675
  year: 2022
  ident: ref23
  article-title: Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides
  publication-title: Molecules
  doi: 10.3390/molecules27092675
– year: 2016
  ident: ref32
– volume: 10
  start-page: 10
  year: 2020
  ident: ref35
  article-title: A how-to guide for mode of action analysis of antimicrobial peptides
  publication-title: Front. Cell Infect. Microbiol.
  doi: 10.3389/fcimb.2020.540898
– volume: 12
  start-page: 12
  year: 2022
  ident: ref18
  article-title: Global threat of Carbapenem-resistant gram-negative bacteria
  publication-title: Front. Cell Infect. Microbiol.
  doi: 10.3389/fcimb.2022.823684
– volume: 501
  start-page: 146
  year: 2001
  ident: ref9
  article-title: Optimization of the antimicrobial activity of magainin peptides by modification of charge
  publication-title: FEBS Lett.
  doi: 10.1016/S0014-5793(01)02648-5
– volume: 9
  start-page: 66
  year: 2020
  ident: ref11
  article-title: Trematocine, a novel antimicrobial peptide from the Antarctic fish Trematomus bernacchii: identification and biological activity
  publication-title: Antibiotics (Basel).
  doi: 10.3390/antibiotics9020066
– volume: 5
  start-page: e00775-20
  year: 2020
  ident: ref31
  article-title: A ceftazidime-avibactam-resistant and Carbapenem-susceptible Klebsiella pneumoniae strain harboring blaKPC-14 isolated in New York City
  publication-title: mSphere
  doi: 10.1128/mSphere.00775-20
– volume: 1866
  start-page: 184260
  year: 2024
  ident: ref38
  article-title: Tryptophan-and arginine-rich antimicrobial peptides: anti-infectives with great potential
  publication-title: Biochim. Biophys. Acta Biomembr.
  doi: 10.1016/j.bbamem.2023.184260
– volume: 65
  start-page: 601
  year: 2010
  ident: ref36
  article-title: Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/dkq037
– volume: 399
  start-page: 629
  year: 2022
  ident: ref30
  article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)02724-0
– volume: 80
  start-page: 374
  year: 2012
  ident: ref25
  article-title: Prediction of protein secondary structure from circular dichroism using theoretically derived spectra
  publication-title: Proteins
  doi: 10.1002/prot.23188
– volume: 265
  start-page: 116072
  year: 2024
  ident: ref19
  article-title: Antimicrobial peptides: An alternative to traditional antibiotics
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2023.116072
– volume-title: WHO Bacterial Priority Pathogens List, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance [Internet]
  year: 2024
  ident: ref39
– ident: ref14
SSID ssj0000402000
Score 2.3980992
Snippet This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two...
IntroductionThis study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1447301
SubjectTerms antimicrobial peptides
antimicrobial resistance
ESKAPE pathogens
membranolytic agents
Microbiology
multi-drug resistant bacteria
SummonAdditionalLinks – databaseName: Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlEOiltEk_3CZBgd6KqWXZstzbJmwICS2FJpCb0CdraOwl9hbyK_KXOyM7y24J7aUngy2PxcyzNc-S3hDyEVJUgIa1qa0LnhahqlLNCp_C0OBykTvHBW5w_vpNnF8XFzflzUapL1wTNsoDj477nPnSay95qEtb6GCNk4XLdMhqyY3Vka3DmLdBpuI3GGlRlo27ZICF1RCmxhrgg3mB85mI662RKAr2P5Vl_rlYcmP0OXtJXkxpI52N3X1Fnvl2j-yOhSTv98nD1R1qr3Y4S546ANUv7yj4rLltotAS3LrE5SvO9xQ3lFBI--isHQDlYJCGpl_QycTtqqcGfxJau9BN84UuO0irh2jNjNLOYE3jjqweDrqB_JLOf1zOvs8pljfu4Er_mlyfza9Oz9Op1EJqgR8PqZdaG2OlC05A9LiWsoRMhgc466ogSgdOFLmVwgKNLW1tcmErW2Qe5Xt8zd-QnbZr_TtCeV5pUWqmBfMQe29MxXTgwlQiyMBEQtij25WddMixHMZPBXwEQ6ViqBSGSk2hSsin9T3LUYXjr61PMJrrlqigHU8ArtSEK_UvXCXk-BELCt44nEbRre9WveKo3SghL5UJeTtiY_0oDuyXASlNiNxCzVZftq-0zSKqejPGOdgt3_-P3n8gz9EjcaVidUB2hruVP4TsaTBH8UX5DTOsHgs
  priority: 102
  providerName: Directory of Open Access Journals
Title Trematocine-derived antimicrobial peptides from the Antarctic fish Trematomus bernacchaii: potent antibacterial agents against ESKAPE pathogens
URI https://www.ncbi.nlm.nih.gov/pubmed/39171261
https://www.proquest.com/docview/3095681058
https://pubmed.ncbi.nlm.nih.gov/PMC11335685
https://doaj.org/article/0e5eae83f95c4afcbd84d0af0983bca0
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9NAEF7OE-W-iO_Gl2MFv0kkm002G0GkSs9DORG8Qr-Ffb0G7pLapOL9C3-yM5u0WLnzSwt5maQ7M51ndneeIeQVQFQwDWNiU2Y8znxRxIplLobQYFORWssFFjiffBXHs-zzPJ_vkU27o3EAuytTO-wnNVudv_n14_I9OPw7zDgh3oIGaqMh1UszXKpEk71BbkJkKrCjwckI98M_MyZLoSqFCYELAul8qKO5RswBuc0hnWGpYDthK7D7XwVJ_91Z-VeoOrpL7owYk04Go7hH9lxzn9wauk5ePiC_T1dI1NriknpswQJ_OkthgOuLOrAywa1L3OtiXUex-oQCRqSTpgeXAIHU192CjiIu1h3VOKNozELVNX1Lly2A8D6I0wMRNIhTWL_VwZeqAY3S6fcvk29Tis2QWzjTPSSzo-npx-N4bMwQG8im-9hJpbQ20norQNdcSZkD7uEejtrCi9zCgIrUSGEg6c1NqVNhCpMlDsl-XMkfkf2mbdwTQnlaKJErpgRzYClO64Ipz4UuhJeeiYiwzbhXZmQtx-YZ5xVkL6i2KqitQrVVo9oi8np7z3Lg7Pjv1R9QndsrkW87HGhXZ9XovlXicqec5L7MTaa80VZmNlE-KSXXRiURebkxhgr8ExddVOPadVdxZHqUgGJlRB4PxrF91Ma4IiJ3zGbnXXbPNPUicIAzxjnIzZ9eK_QZOcCfGTYrFs_Jfr9auxcAoHp9GCYe4PPTnB0GD_kDtDsbYw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trematocine-derived+antimicrobial+peptides+from+the+Antarctic+fish+Trematomus+bernacchaii+%3A+potent+antibacterial+agents+against+ESKAPE+pathogens&rft.jtitle=Frontiers+in+microbiology&rft.au=Squitieri%2C+Damiano&rft.au=Massaro%2C+Federica&rft.au=Graziano%2C+Monica+Mollica&rft.au=Borocci%2C+Stefano&rft.date=2024-08-07&rft.issn=1664-302X&rft.eissn=1664-302X&rft.volume=15&rft.spage=1447301&rft_id=info:doi/10.3389%2Ffmicb.2024.1447301&rft_id=info%3Apmid%2F39171261&rft.externalDocID=39171261
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon